The tale of Wockhardt Yellow is a stark reminder about the fragility in pharmaceutical integrity. What started as a seemingly harmless yellow dye in medication quickly transformed into a significant crisis, exposing critical weaknesses in the manufacturing and quality regulation. This profound tale underscores the essential need for stringent regul